Trial intelligence / Profile preview

Vortioxetine for PTSD

NCT02637895Phase 4Completed

Sponsor
University of Miami
Start
Dec 2016
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vortioxetine in post-traumatic stress disorder (PTSD), sponsored by University of Miami. Started Dec 2016; status: completed.

02

Drugs

vortioxetine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT02637895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02637895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call